Another major metabolite, CK, prevents HFD/STZ-induced diabetic nephropathy and high glucose-mediated mesangial cell damage by inhibiting NLRP3 inflammasome activation and the NF-κB/p38 pathway (Song et al., 2018). Here, NLRP3 is linked to diabetic kidney disease.